Dysregulated iron homeostasis is strongly associated with multiorgan failure and early mortality in acute-on-chronic liver failure

Hepatology

Volumn 61, Issue 4, 2015, Pages 1306-1320

  Maras, Jaswinder Singh ^a   Maiwall, Rakhi ^b   Harsha, H C ^a   Das, Sukanta ^a   Hussain, Md Shabir ^a   Kumar, Chandan ^b   Bihari, Chhagan ^a   Rastogi, Archana ^a   Kumar, Manoj ^b   Trehanpati, Nirupama ^a   Sharma, Shvetank ^a   Pandey, Akhilesh ^a,c   Sarin, Shiv Kumar ^a,b  

^a INSTITUTE OF LIVER AND BILIARY SCIENCES   (India)

^b International Technology Park   (India)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CASPASE 3; CASPASE 8; CERULOPLASMIN; CYTOCHROME B; ENZYME; FERRITIN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HEPCIDIN; HFE PROTEIN; IRON; IRON REGULATORY FACTOR; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; TELOMERIC REPEAT BINDING FACTOR 2; TRANSFERRIN; TRANSFERRIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ACUTE ON CHRONIC LIVER FAILURE; ADOLESCENT; ADULT; AGED; ALCOHOL LIVER DISEASE; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; AUTOPHAGY; BIOCATALYST; CERULOPLASMIN BLOOD LEVEL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; FERRITIN BLOOD LEVEL; FLOW CYTOMETRY; FOLLOW UP; GENE EXPRESSION; HEPATIC ENCEPHALOPATHY; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; INFLAMMATION; IRON BALANCE; IRON BLOOD LEVEL; IRON STORAGE; IRON TRANSPORT; LIVER CIRRHOSIS; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE; TRANSFERRIN BLOOD LEVEL; UPREGULATION; ACUTE-ON-CHRONIC LIVER FAILURE; COMPLICATION; HOMEOSTASIS; IRON METABOLISM DISORDER; MIDDLE AGED; YOUNG ADULT;

ACUTE-ON-CHRONIC LIVER FAILURE; ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HOMEOSTASIS; HUMANS; IRON METABOLISM DISORDERS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; YOUNG ADULT;

EID: 84925355865     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27636     Document Type: Article

References (37)

1. Jalan R, Williams R. Acute-on-chronic liver failure: pathophysiological basis of therapeutic options. Blood Purif 2002;20:252-261.
2. Laleman W, Verbeke L, Meersseman P, Wauters J, van Pelt J, Cassiman D, et al. Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions. Expert Rev Gastroenterol Hepatol 2011;5:523-537; quiz, 537.
3. Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 2009;3:269-282.
4. Oettl K, Stadlbauer V, Krisper P, Stauber RE. Effect of extracorporeal liver support by molecular adsorbents recirculating system and Prometheus on redox state of albumin in acute-on-chronic liver failure. Ther Apher Dial 2009;13:431-436.
5. Xu X, Liu X, Ling Q, Wei Q, Liu Z, Zhou L, et al. Artificial liver support system combined with liver transplantation in the treatment of patients with acute-on-chronic liver failure. PLoS One 2013;8:e58738.
6. Ioannou GN, Dominitz JA, Weiss NS, Heagerty PJ, Kowdley KV. The effect of alcohol consumption on the prevalence of iron overload, iron deficiency, and iron deficiency anemia. Gastroenterology 2004;126:1293-1301.
7. Lipiński P, Starzyński RR, Styś A, Stracilo M. [Iron homeostasis, a defense mechanism in oxidative stress]. [Article in Polish]. Postepy Biochem 2010;56:305-316.
8. Zanninelli G, Loréal O, Brissot P, Konijn AM, Slotki IN, Hider RC, Ioav Cabantchik Z. The labile iron pool of hepatocytes in chronic and acute iron overload and chelator-induced iron deprivation. J Hepatol 2002;36:39-46.
9. Slater AF, Stefan C, Nobel I, van den Dobbelsteen DJ, Orrenius S. Signalling mechanisms and oxidative stress in apoptosis. Toxicol Lett 1995;82-83:149-153.
10. Batts KP. Iron overload syndromes and the liver. Mod Pathol 2007;20(Suppl 1):S31-S39.
11. Bergmann OM, Mathahs MM, Broadhurst KA, Weydert JA, Wilkinson N, Howe JR, et al. Altered expression of iron regulatory genes in cirrhotic human livers: clues to the cause of hemosiderosis? Lab Invest 2008;88:1349-1357.
12. Kalantar-Zadeh K, Rodriguez RA, Humphreys MH. Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients. Nephrol Dial Transplant 2004;19:141-149.
13. Maiwall R, Kumar S, Chaudhary AK, Maras J, Wani Z, Kumar C, et al. Serum ferritin predicts early mortality in patients with decompensated cirrhosis. J Hepatol 2014;61:43-50.
14. Ozawa E, Abiru S, Nagaoka S, Yano K, Komori A, Migita K, et al. Ferritin/alanine aminotransferase ratio as a possible marker for predicting the prognosis of acute liver injury. J Gastroenterol Hepatol 2011;26:1326-1332.
15. De Domenico I, McVey Ward D, Kaplan J. Regulation of iron acquisition and storage: consequences for iron-linked disorders. Nat Rev Mol Cell Biol 2008;9:72-81.
16. Petrat F, de Groot H, Rauen U. Subcellular distribution of chelatable iron: a laser scanning microscopic study in isolated hepatocytes and liver endothelial cells. Biochem J 2001;356:61-69.
17. Di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR. Measurements of iron status in patients with chronic hepatitis. Gastroenterology 1992;102:2108-2113.
18. Riley TR III, Bhatti AM. Preventive strategies in chronic liver disease: part I. Alcohol, vaccines, toxic medications and supplements, diet and exercise. Am Fam Physician 2001;64:1555-1560.
19. Weaver LK, Pioli PA, Wardwell K, Vogel SN, Guyre PM. Up-regulation of human monocyte CD163 upon activation of cell-surface Toll-like receptors. J Leukoc Biol 2007;81:663-671.
20. Delaby C, Rondeau C, Pouzet C, Willemetz A, Pilard N, Desjardins M, Canonne-Hergaux F. Subcellular localization of iron and heme metabolism related proteins at early stages of erythrophagocytosis. PLoS One 2012;7:e42199.
21. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, Moestrup SK. Identification of the haemoglobin scavenger receptor. Nature 2001;409:198-201.
22. Ballarín J, Arce Y, Torra Balcells R, Diaz Encarnación M, Manzarbeitia F, Ortiz A, et al. Acute renal failure associated to paroxysmal nocturnal haemoglobinuria leads to intratubular haemosiderin accumulation and CD163 expression. Nephrol Dial Transplant 2011;26:3408-3411.
23. Knutson M, Wessling-Resnick M. Iron metabolism in the reticuloendothelial system. Crit Rev Biochem Mol Biol 2003;38:61-88.
24. Kim DJ, Kim HY, Kim SJ, Hahn TH, Jang MK, Baik GH, et al. Helicobacter pylori infection and peptic ulcer disease in patients with liver cirrhosis. Korean J Intern Med 2008;23:16-21.
25. Prus E, Fibach E. Flow cytometry measurement of the labile iron pool in human hematopoietic cells. Cytometry A 2008;73:22-27.
26. Prus E, Fibach E. The labile iron pool in human erythroid cells. Br J Haematol 2008;142:301-307.
27. Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet 2010;376:190-201.
28. Fernaeus S, Land T. Increased iron-induced oxidative stress and toxicity in scrapie-infected neuroblastoma cells. Neurosci Lett 2005;382:217-220.
29. Tan TC, Crawford DH, Franklin ME, Jaskowski LA, Macdonald GA, Jonsson JR, et al. The serum hepcidin:ferritin ratio is a potential biomarker for cirrhosis. Liver Int 2012;32:1391-1399.
30. Kohgo Y, Ikuta K, Ohtake T, Torimoto Y, Kato J. Body iron metabolism and pathophysiology of iron overload. Int J Hematol 2008;88:7-15.
31. Weismuller TJ, Kirchner GI, Scherer MN, Negm AA, Schnitzbauer AA, Lehner F, et al. Serum ferritin concentration and transferrin saturation before liver transplantation predict decreased long-term recipient survival. Hepatology 2011;54:2114-2124.
32. Horl WH, Schmidt A. Low hepcidin triggers hepatic iron accumulation in patients with hepatitis C. Nephrol Dial Transplant 2014;29:1141-1144.
33. Costa-Matos L, Batista P, Monteiro N, Simoes M, Egas C, Pereira J, et al. Liver hepcidin mRNA expression is inappropriately low in alcoholic patients compared with healthy controls. Eur J Gastroenterol Hepatol 2012;24:1158-1165.
34. Ma J, Liu L, Che G, Yu N, Dai F, You Z. The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time. BMC Cancer 2010;10:112.
35. Andrews M, Arredondo M. Hepatic and adipocyte cells respond differentially to iron overload, hypoxic and inflammatory challenge. Biometals 2012;25:749-759.
36. Tan TC, Crawford DH, Jaskowski LA, Subramaniam VN, Clouston AD, Crane DI, et al. Excess iron modulates endoplasmic reticulum stress-associated pathways in a mouse model of alcohol and high-fat diet-induced liver injury. Lab Invest 2013;93:1295-1312.
37. Wang K. Molecular mechanisms of hepatic apoptosis. Cell Death Dis 2014;5:e996. doi:10.1038/cddis.2013.499.